Effect of Metformin and Rosiglitazone Over no Diabetic With Metabolic Syndrome Patients.

NCT04148183 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Insulin Resistance

Interventions

DRUG: Metformin group
DRUG: Rosiglitazone group
DRUG: Placebo oral tablet

Sponsor

J JESUS VENEGAS, MD

Collaborators

[object Object]
[object Object]